PTIX Insider Trading

Insider Ownership Percentage: 37.00%
Insider Buying (Last 12 Months): $16,330.00
Insider Selling (Last 12 Months): $0.00

Protagenic Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Protagenic Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Protagenic Therapeutics Share Price & Price History

Current Price: $0.56
Price Change: +0.30 (1.20%)
As of 02/6/2023 01:00 AM ET

This chart shows the closing price history over time for PTIX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Get the Name & Ticker Here

Protagenic Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/17/2022Alexander K ArrowCFOBuy23,000$0.71$16,330.00143,260View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Protagenic Therapeutics (OTCMKTS:PTIX)

3.47% of Protagenic Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PTIX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Protagenic Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Renaissance Technologies LLC50,200$36K0.0%-50.9%0.290%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC102,200$83K0.0%+69.2%0.592%Search for SEC Filing on Google Icon
2/1/2022FNY Investment Advisers LLC74,800$0.10M0.1%N/A0.441%Search for SEC Filing on Google Icon
1/10/2022FNY Investment Advisers LLC74,800$0.10M0.1%N/A0.441%Search for SEC Filing on Google Icon
11/15/2021Oracle Investment Management Inc.500,000$0.94M0.1%N/A2.980%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC19,718$57K0.0%N/A0.135%Search for SEC Filing on Google Icon
8/16/2021State Street Corp98,800$0.29M0.0%N/A0.675%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp22,485$65K0.0%N/A0.154%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC59,083$0.17M0.0%N/A0.403%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.20,783$60K0.0%N/A0.142%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC12,900$37K0.0%N/A0.088%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Protagenic Therapeutics logo
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Read More on Protagenic Therapeutics

Today's Range

Now: $0.56
Low: $0.55
High: $0.57

50 Day Range

MA: $0.48
Low: $0.35
High: $0.59

52 Week Range

Now: $0.56
Low: $0.33
High: $1.22

Volume

18,279 shs

Average Volume

26,124 shs

Market Capitalization

$9.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13

Who are the company insiders with the largest holdings of Protagenic Therapeutics?

Protagenic Therapeutics' top insider shareholders include:
  1. Alexander K Arrow (CFO)
Learn More about top insider investors at Protagenic Therapeutics.
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
[Full Story]